Case Report

Published on 06 Jun 2019

Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer

in Thoracic Oncology

Anne Sibille
Romain Alfieri
Olivier Malaise
Nancy Detrembleur
Michelle Pirotte
Renaud Louis
Bernard Duysinx

Frontiers in Oncology

doi 10.3389/fonc.2019.00478

3,734 views
16 citations

Original Research

Published on 31 May 2019

Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015

in Thoracic Oncology

Yu Jie Zhong
Yi Feng Wen
Hai Ming Wong
Guosheng Yin
Ruitao Lin
Shuan Ying Yang

Frontiers in Oncology

doi 10.3389/fonc.2019.00404

8,292 views
24 citations

Perspective

Published on 26 Apr 2019

A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer

in Thoracic Oncology

Montreh Tavakkoli
Cy R. Wilkins
Jodi V. Mones
Michael J. Mauro

Frontiers in Oncology

doi 10.3389/fonc.2019.00295

6,886 views
54 citations

Original Research

Published on 24 Apr 2019

Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions

in Thoracic Oncology

Tina D. Tailor
Xiayu Rao
Michael J. Campa
Jing Wang
Simon G. Gregory
Edward F. Patz Jr.

Frontiers in Oncology

doi 10.3389/fonc.2019.00317

6,984 views
20 citations

Original Research

Published on 18 Apr 2019

Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules

in Thoracic Oncology

Yijiu Ren
Shujun Huang
Chenyang Dai
Dong Xie
Larry Zheng
Huikang Xie
Hui Zheng
Yunlang She
Fangyu Zhou
Yue Wang

Frontiers in Oncology

doi 10.3389/fonc.2019.00288

9,831 views
17 citations

Original Research

Published on 17 Apr 2019

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)

in Thoracic Oncology

Andrés F. Cardona
Leonardo Rojas
Zyanya Lucia Zatarain-Barrón
Alejandro Ruiz-Patiño
Luisa Ricaurte
Luis Corrales
Claudio Martín
Helano Freitas
Vladmir Cláudio Cordeiro de Lima
July Rodriguez

Frontiers in Oncology

doi 10.3389/fonc.2019.00254

8,808 views
25 citations

Systematic Review

Published on 16 Apr 2019

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

in Thoracic Oncology

Alfredo Addeo
Giuseppe Luigi Banna
Giulio Metro
Massimo Di Maio

Frontiers in Oncology

doi 10.3389/fonc.2019.00264

12,481 views
87 citations

Original Research

Published on 05 Apr 2019

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis

in Thoracic Oncology

Kaiyuan Wang
Yu Zheng
Yinli Yang
Jian Wang
Baihui Li
Feng Wei
Hongwei Zhao
Xiubao Ren

Frontiers in Oncology

doi 10.3389/fonc.2019.00235

3,150 views
10 citations

Review

Published on 29 Mar 2019

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer

in Thoracic Oncology

Jose M. Pacheco
D. Ross Camidge
Robert C. Doebele
Erin Schenk

Frontiers in Oncology

doi 10.3389/fonc.2019.00195

15,378 views
53 citations

Original Research

Published on 26 Mar 2019

PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival

in Thoracic Oncology

Shaochuan Liu
Tingting Qin
Yanan Jia
Kai Li

Frontiers in Oncology

doi 10.3389/fonc.2019.00189

3,901 views
14 citations

Mini Review

Published on 19 Mar 2019

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

in Thoracic Oncology

Alex Friedlaender
Giuseppe Banna
Umberto Malapelle
Pasquale Pisapia
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2019.00166

13,248 views
71 citations

Clinical Trial

Published on 11 Mar 2019

Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

in Thoracic Oncology

Karen L. Reckamp
Paul H. Frankel
Nora Ruel
Philip C. Mack
Barbara J. Gitlitz
Tianhong Li
Marianna Koczywas
Shirish M. Gadgeel
Mihaela C. Cristea
Chandra P. Belani

Frontiers in Oncology

doi 10.3389/fonc.2019.00132

7,003 views
34 citations

Review

Published on 05 Mar 2019

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

in Thoracic Oncology

Jatta Saarenheimo
Natalja Eigeliene
Heidi Andersen
Marja Tiirola
Antti Jekunen

Frontiers in Oncology

doi 10.3389/fonc.2019.00129

16,548 views
68 citations

Original Research

Published on 15 Feb 2019

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma

in Thoracic Oncology

Jian-Guo Zhou
Hua Zhong
Juan Zhang
Su-Han Jin
Raheleh Roudi
Hu Ma

Frontiers in Oncology

doi 10.3389/fonc.2019.00078

6,937 views
23 citations

Case Report

Published on 22 Jan 2019

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

in Thoracic Oncology

Masahiro Yamasaki
Wakako Daido
Naomi Saito
Kunihiko Funaishi
Takenori Okada
Kazuma Kawamoto
Yu Matsumoto
Naoko Matsumoto
Masaya Taniwaki
Nobuyuki Ohashi

Frontiers in Oncology

doi 10.3389/fonc.2019.00004

7,316 views
23 citations

Review

Published on 09 Jan 2019

ALK Inhibitors in the Treatment of ALK Positive NSCLC

in Thoracic Oncology

Muhammad Khan
Jie Lin
Guixiang Liao
Yunhong Tian
Yingying Liang
Rong Li
Mengzhong Liu
Yawei Yuan

Frontiers in Oncology

doi 10.3389/fonc.2018.00557

19,921 views
70 citations

Navigation group

Articles

Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer

Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015

A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer

Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions

Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer

PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

ALK Inhibitors in the Treatment of ALK Positive NSCLC